ONC - BeiGene Corp Long-Term Debt

Brandmark of BeiGene Oncology (ONC)

BeiGene Ltd (ONC) combines capital-intensive oncology development with high margins on finished molecules and absolute demand resilience during crises. The status of the corporation's long-term loans and borrowings visualizes this financial balance, where the value of 1.50 serves as the baseline indicator of the current load. Business scaling is supported by the active recruitment of leading experts, which guarantees technological growth.

ONC - beigene.com Company Long-Term Liabilities over the range 07/04/2022 - 10/30/2026

BeiGene Corp - analytical breakdowns and key metrics (ONC)

- current quotes and average value forecast:
Stock Quotes beigene.com|ONC - Analyst Consensus Forecast
- market capitalization statistics:
Market Value BeiGene|ONC - Total Company Value
- book capitalization data:
Accounting Value of a Share BeiGene|ONC - Company Net Assets|Market Value to Book Value beigene.com|ONC - Company Total Assets
- debt level and financial liquidity data:
Total Debt to Equity Ratio BeiGene Ltd|ONC - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital BeiGene Oncology|ONC - Company Debts|Debt to Net Assets Ratio BeiGene|ONC - Company Long-Term Debts|Short-Term Debt BeiGene|Quick Liquidity beigene.com
- earnings and market ratios statistics:
ONC - Net Profit
Analysis of all company metrics:beigene.com
Mass-produced product of BeiGene Corp

To objectively assess the operational successes of BeiGene Ltd (ONC), it is essential for investors to understand the structure of its capital obligations. Analyzing the dynamics of the firm's long-term borrowings reveals the volume of loans with maturities exceeding one year, which determines the business's financial stability. The stability of this metric indicates the company's maturity, yet it may signal a slowdown in expansion. Amid stringent FDA oversight and costly R&D developments, this debt serves as the foundation for overcoming high technological barriers.

Who BeiGene Ltd competes with

HALO - Company Long-Term Liabilities|Revolution Medicines, Inc. - Company Long-Term Debts|Long-Term Debt Ascentage Pharma Group International|CG Oncology Corp (CGON) - Company Long-Term Debt|UroGen Pharma Corp - Company Long-Term Loans and Borrowings|Company Long-Term Liabilities BCAX|PSNL: Company Long-Term Loans and Borrowings|Company Long-Term Debts ERAS|Company Long-Term Liabilities Delcath Systems Inc DCTH|YmAbs - Company Long-Term Liabilities|Company Long-Term Debts Aura Corp AURA|CADL - Company Long-Term Debt|Company Long-Term Loans and Borrowings ARAY (accuray.com)|SLS: Company Long-Term Debts|Long-Term Debt Actuate Therapeutics Inc. (ACTU)|CTOR (Citius Oncology, Inc) - Company Long-Term Debts|Company Long-Term Debt HURA|Company Long-Term Debts TARA|FATE - Long-Term Debt|Company Long-Term Debts WHWK (Aadi Bioscience)|Long-Term Debt Volume TScan Therapeutics Inc (TCRX)|Champions Oncology Corp - Company Long-Term Debts|Long-Term Indebtedness XBiotech Inc. (XBIT)|CVM: Company Long-Term Debts|Long-Term Debt ostherapies.com (OSTX)|Company Long-Term Debt Radiopharm Theranostics Limited|Company Long-Term Indebtedness ARTV (Artiva)|Company Long-Term Debts ANL|VERU - Long-Term Debt|Tempest Therapeutics - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings XLO|RENB - Company Long-Term Debt|MURA: Company Long-Term Debt|KAPA (kairospharma.com) - Company Long-Term Liabilities|OKUR: Amount of Long-Term Liabilities|GDTC (CytoMed Therapeutics Ltd) - Company Long-Term Debts|Company Long-Term Indebtedness CRIS (Curis Corp)|Company Long-Term Debt Apollomics, Inc. (APLM)|THAR - Long-Term Debt|Company Long-Term Debt Advanced Biomed ADVB|GNPX: Company Long-Term Indebtedness|Calidi Bio - Company Long-Term Debts|Sunshine Biopharma Inc. (SBFM) - Company Long-Term Liabilities|XBIO: Company Long-Term Debts|Company Long-Term Liabilities Salarius Pharmaceuticals Inc|PPBT (Purple Biotech Corp) - Company Long-Term Debts|Company Long-Term Debts AON|Company Long-Term Debt BeiGene, Ltd. (BGNE)|checkpointtx.com - Company Long-Term Indebtedness|Company Long-Term Debts ELEV (Elevation Oncology, Inc.)|ICAD - Company Long-Term Liabilities|Ikena - Company Long-Term Debts|Long-Term Debt Notable Labs Corp|viracta.com (VIRX) - Company Long-Term Debt|morphosys.com - Company Long-Term Loans and Borrowings|Company Long-Term Liabilities NAYA|AAPGV: Company Long-Term Loans and Borrowings